Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Phyton Biotech to Conduct Meetings During 37th Annual J.P. Morgan Conference
Phyton Biotech will be attending the 37th Annual J.P. Morgan Health Care Conference from January 7 to 10, 2019 in San Francisco.
Phyton Biotech Announces Appointment of New General Manager
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
Phyton Biotech showcases Plant Cell Fermentation Technology at Europe’s largest biotechnology partnering conference
Phyton Biotech recently attended BIO-Europe 2018: the 24th Annual International Partnering Conference in Copenhagen, Denmark.
Phyton Biotech connects with global pharmaceutical leaders at BIOEurope in Copenhagen
Phyton Biotech will be at BIOEurope in beautiful Copenhagen from November 5-7. Visit us at the Life Science Nord booth #97 and learn how our unique Plant Cell Fermentation (PCF®) platform can support your company's needs for plant-derived active ingredients.
Phyton Biotech showcases plant cell fermentation technology at world’s largest pharmaceutical industry trade show
Phyton Biotech recently attended CPhI Worldwide in Madrid, Spain, where we showcased our award-winning and environmentally responsible Plant Cell Fermentation (PCF ®) technology for the production of Paclitaxel and Docetaxel and other high-value phytochemicals.
Phyton Biotech joins pharmaceutical leaders at CPhI Worldwide in Madrid
As global leaders in plant cell fermentation, Phyton Biotech is pleased to announce our participation at CPhI Worldwide in Madrid, Spain from October 9-11, 2018.